India Orders Bayer to License a Patented Drug

March 12, 2012
New York Times
By Vikas Bajaj and Andrew Pollack

India’s government on Monday authorized a drug manufacturer to make and sell a generic copy of a patented Bayer cancer drug, saying that Bayer charged a price that was unaffordable to most of the nation.

The decision by the controller general of patents, designs and trademarks was the first time a so-called compulsory license of a patented drug had been granted in India. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**